SURGALIGN HOLDINGS, INC.
Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | |
|---|---|---|---|---|---|---|
| Revenue | $82.0M | $90.5M | $101.7M | $117.4M | $92.1M | $280.3M |
| Operating income | −$78.5M | −$137.3M | −$198.0M | −$242.9M | −$64.8M | $29.3M |
| Net income | −$54.6M | −$84.7M | −$33.8M | −$211.6M | −$3.1M | $6.9M |
| Total assets | $70.2M | $123.8M | $122.7M | $344.5M | $360.2M | — |
| Total liabilities | $86.0M | $105.6M | $98.5M | $243.5M | $112.4M | — |
| Equity | −$25.7M | $8.2M | $24.2M | $34.6M | $181.5M | $181.5M |
| EPS (diluted) | $-8.33 | $-20.72 | $-0.45 | $-3.02 | $-0.09 | $0.05 |
| Shares out. | 198.8M | 110.3M | 74.6M | 75.2M | 63.5M | 60.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- −95.7%
- Net margin
- −66.6%
- Return on equity
- 212.2%
- Return on assets
- −77.7%
- Return on capital (ROCE)
- −159.8%
- Liabilities / assets
- 122.4%
- Debt / equity
- —
- Book value / share
- $-0.13
- Revenue growth (YoY)
- −9.4%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -33.47distress
- Accruals / assets
- −3.6%clean
- Beneish M-Score
- -2.60normal
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 5 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 14, 2023
- NT 10-Qmissed a reporting deadline ↗Nov 10, 2020
- NT 10-Qmissed a reporting deadline ↗Aug 11, 2020
- NT 10-Qmissed a reporting deadline ↗Jun 26, 2020
- NT 10-Kmissed a reporting deadline ↗Mar 17, 2020
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Bankruptcy or receivership · Modified shareholder rights · Changed auditor · Director / officer change · Other material eventSep 29, 2023
- Entered a material agreement · Completed an acquisition or dispositionAug 18, 2023
- Regulation FD disclosure · Other material eventAug 1, 2023
- Regulation FD disclosureJun 23, 2023
- Delisting / listing-standard notice · Regulation FD disclosureJun 23, 2023
- Entered a material agreement · Bankruptcy or receivership · Debt acceleration / triggering event · Regulation FD disclosureJun 20, 2023
- Costs from exit or disposal · Director / officer changeJun 20, 2023
- Director / officer changeJun 15, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AFeb 14, 2024
- 15-12GFORM 15-12GNov 13, 2023
- EFFECTOct 6, 2023
- EFFECTOct 6, 2023
- EFFECTOct 6, 2023
- S-8 POSPOST-EFFECTIVE AMENDMENT TO FORM S-8Oct 2, 2023
- S-8 POSPOST-EFFECTIVE AMENDMENT TO FORM S-8Oct 2, 2023
- S-8 POSPOST-EFFECTIVE AMENDMENT TO FORM S-8Oct 2, 2023
- POS AMPOST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3Oct 2, 2023
- POS AMPOST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3Oct 2, 2023
- POS AMPOST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-4Oct 2, 2023
- 8-KCURRENT REPORTSep 29, 2023
- 4FORM 4 SUBMISSIONSep 18, 2023
- 4FORM 4 SUBMISSIONSep 5, 2023
- 8-KFORM 8-KAug 18, 2023